Announcements Trials
Browse Landscape

Phase

Phase 2 68Phase 3 42Phase 1 40Phase 1/2 36Phase NA 3Phase 4 2Phase EARLY_PHASE1 1Phase 2/3 1

Status

Unknown 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 3

Conditions

Multiple Myeloma 3Immunoglobulin Light-chain Amyloidosis 2Neoplasms 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Amyloidosis 1

Interventions

Cyclophosphamide 18fludarabine phosphate 14Peripheral Blood Stem Cell Transplantation 13Cyclosporine 12Whole-Body Irradiation 11Antilymphocyte Serum 10fludarabine 9Exercise 9Busulfan 9Mycophenolic Acid 8Melphalan 8Dexamethasone 8Blood Specimen Collection 8Filgrastim 7Standard of Care 6Radiotherapy 6Behavior Therapy 6Acupuncture Therapy 6Therapeutics 5Specimen Handling 5Palliative Care 5Methotrexate 5Granulocyte Colony-Stimulating Factor 5Etoposide 5Educational Status 5Surveys and Questionnaires 4Stem Cell Transplantation 4Psychiatric Rehabilitation 4Practice Guidelines as Topic 4Methylprednisolone 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Multiple Myeloma × pomalidomide × Clear all
NCT07015021 2025-06-11

DKPD

The First Affiliated Hospital of Soochow University

Phase NA Not yet recruiting
72 enrolled
Plasma cell

Multiple Myeloma

NCT06924424 2025-04-11

Aponermin, Pomalidomide, Dexamethasone for Patients With Relapsed/ Refractory Multiple Myeloma

Peking University People's Hospital

Phase NA Active not recruiting
105 enrolled
Plasma cell

Multiple Myeloma, Neoplasms

NCT05378971 2023-10-04

Clinical Research of Pomalidomide Maintenance Therapy for Primary Multiple Myeloma

LanZhou University

Phase NA Unknown
15 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡